Persistent Chlamydia Infection in Pregnancy

Primary Causes of Persistent Infection

The Centers for Disease Control and Prevention (CDC) recommends test-of-cure for all pregnant women 3-4 weeks after treatment completion because pregnancy regimens "may not be highly efficacious" 1, 2
Both partners must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, as resuming intercourse before this period allows transmission of organisms that have not yet been fully cleared 3, 4, 5
Partners should be evaluated, tested, and treated—not just given antibiotics without confirmation, as the most common cause of "persistent" infection is actually reinfection from untreated or inadequately treated partners 1, 2, 3, 4

Testing performed less than 3 weeks after treatment completion can yield false-positive results from dead organisms, and the CDC explicitly states that diagnostic testing before 3 weeks is not valid 1, 6, 8
For pregnant women specifically, test-of-cure should be performed 3-4 weeks (21-28 days) after treatment completion using NAAT, allowing adequate clearance of dead organisms while still detecting true treatment failures 3, 6

If true treatment failure (proper timing, compliance confirmed): retreat the pregnant woman with an alternative regimen, such as amoxicillin 500mg three times daily for 7 days if initially treated with azithromycin, or azithromycin 1g single dose if initially treated with amoxicillin 2, 3, 4
Retreat the partner simultaneously with a recommended regimen, and emphasize strict sexual abstinence for 7 days after retreatment for both partners 4, 5

Pregnant women have higher rates of treatment failure compared to non-pregnant women, likely due to altered pharmacokinetics and limited antibiotic options, according to the CDC 1, 2
Retest all pregnant women approximately 3 months after treatment regardless of test-of-cure results, as reinfection rates remain high 6